These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25605201)
1. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma. Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201 [TBL] [Abstract][Full Text] [Related]
2. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma. Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949 [TBL] [Abstract][Full Text] [Related]
5. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas. Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma. Amisaki M; Yagyu T; Uchinaka EI; Morimoto M; Hanaki T; Watanabe J; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y Anticancer Res; 2019 Aug; 39(8):4423-4430. PubMed ID: 31366540 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633 [TBL] [Abstract][Full Text] [Related]
9. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma. Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746 [TBL] [Abstract][Full Text] [Related]
10. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma. Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes. Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570 [TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification. Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473 [TBL] [Abstract][Full Text] [Related]
14. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis? Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381 [TBL] [Abstract][Full Text] [Related]
15. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
16. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861 [TBL] [Abstract][Full Text] [Related]
17. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway. Guo W; Li H; Liu H; Ma X; Yang S; Wang Z Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
19. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance. Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379 [TBL] [Abstract][Full Text] [Related]
20. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma. Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]